COVID-19
TOOLBOX
Filter
132
Featured
Language
Document type
Guidelines
44
Fact sheets
43
Studies & Reports
14
Resource Platforms
11
Manuals
7
Infographics
5
Situation Updates
4
Videos
3
Training Material
1
Countries / Regions
Germany
16
Brazil
8
Russia
8
West and Central Africa
6
East and Southern Africa
6
Argentina
6
India
6
Mozambique
3
Africa
3
Latin America and the Carribbean
2
Middle East and North Africa
2
Western and Central Europe
2
South Sudan
2
Turkey
1
Kazakhstan
1
Global
1
Haiti
1
Guinea-Bissau
1
France
1
United Kingdom
1
Portugal
1
Spain
1
South Korea
1
Belarus
1
Vietnam
1
Angola
1
Authors & Publishers
World Health Organization WHO
51
Africa CDC Centres for Disease Control and Prevention
12
African Union
12
Robert-Koch-Institut RKI
7
Ministerio de Salud Argentina
6
European Medicines Agency EMA
5
Organisation Mondiale de la Santé OMS
5
OPAS
4
World Health Organization WHO, et al.
4
World Health Organization WHO, Regional Office of Europe
4
Dirección de Control de Enfermedades Inmunoprevenibles
3
Organización Mundial de la Salud OMS
3
Feraud, H.
2
OPAS, OMS
2
Organización Mundial de Saude and OPAS
2
Pan American Health Organisation PAHO
2
Paul Ehrlich Institute
2
World Health Organisation (WHO)
2
and C. Wonodi
1
Bayerisches Staatsministerium für Gesundheit und Pflege
1
BBC
1
Bharat Biotech
1
BioNTech
1
Camp, R. and C. Hoffmann
1
CDC
1
Clinical Care Options
1
Coision Nacional de Seguridad en Vacunas
1
Deutsches Grünes Kreuz e. V., Marburg, Robert Koch-Institut RKI
1
Food and Drug Administration
1
Gesellschaft für Thrombose-undHämostaseforschung e.V. GTH
1
Greinacher, A., et al.
1
Harding-Zentrum für Risikokompetenz
1
Kamps, B.S.
1
Kamradt, T., and B.S. Kamps
1
Kamradt, T., B.S. Kamps J. García-Rosales Delgado
1
Kim, A.
1
Knoll, M.D.
1
Logunov, D.Y, et al.
1
Mauder, S.
1
Mauder, S., K. Geffert
1
MEDBOX
1
Medicines and Healthcare products Regulatory Agency (MHRA) UK
1
New England Journal of Medicine
1
New York Times
1
Organización Mundial de la Salud
1
Organização Mundial da Saúde (OMS)
1
Pfizer
1
Polack, F.P. et al.
1
Robert-Koch-Instiut RKI
1
S.R. Lewin and R. Sherer
1
TASS russian news agency
1
The Gamaleya National Center Russia
1
UNICEF
1
Vaccine Centre at the London School of Hygiene & Tropical Medicine
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
World Health Organization WHO, SAGE
1
Zimmer, C, J. Corum and S. Wee
1
Всемирная организация здравоохранения
1
Publication Years
Category
Countries
55
Key Resources
2
Women & Child Health
1
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato... more
Vaccinator's Manual. MODERNA Vaccine
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
Februrar 2021
FEY ENFOMASYON POU MOUN K’AP RESEVWA AVEK MOUN K’AP BAY SWEN OTORIZASYON POU ITILIZASYON IJANS (EUA) POU VAKSIN MODERNA COVID-19 POU ANPECHE CORONAVIRUSDISEASE 2019 (COVID-19) NAN PERSONN 18 ANE AK PI GRAN
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021 Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4

Impfung & COVID-19

Mauder, S., K. Geffert MEDBOX (2021) CC
MEDBOX Issue Brief no. 7, Dec. 2020 Die Impfung gegen die Ausbreitung des SARS-CoV-2-Virus stellt einen Meilenstein in der Bekämpfung der Pandemie dar. Für den Erfolg der Impfung unabdingbar ist eine gute Kommunikation und Aufklärung der Bevölkerung. Im Folgenden sind einige Informationen zur I... more
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
Manufacturers: SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])] Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)] Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir... more
July 2021
February 2021. Improving our response to the ongoing COVID-19 pandemic in Africa requires regularly updated information, constant innovation, and considerable support towards research and development (R&D) for priorities that respond to the African realities. Shaping the research agenda and stimula... more
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do... more
10 May 2021. Manufactureres: SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])] Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)] The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto... more
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS